KCG
ACER

Knight Capital Group’s Acer Therapeutics Inc ACER Stock Holding History

Knight Capital Group’s Portfolio ACER Stock Details ACER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$53K Buy
+425
New +$62.1K ﹤0.01% 3054

Other funds holding ACER

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SKK
Shepherd Kaplan Krochuk Boston, Massachusetts $119M AUM 8.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PGFC
Peapack-Gladstone Financial Corp Bedminster, New Jersey $7.82B AUM 21.06% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Knight Capital Group's ACER Position: Q2 2013 in Review

Knight Capital Group opened a new position in Acer Therapeutics Inc (ACER) in Q2 2013: 425 shares worth $53K. The stake represents ﹤0.01% of the portfolio and ranks #3054 among its holdings.

12 funds tracked by Wall St. Rank hold ACER as of Q2 2013.

  • Knight Capital Group held 425 shares of Acer Therapeutics Inc worth $53K as of Q2 2013.
  • Acer Therapeutics Inc was a new Knight Capital Group position in Q2 2013.
  • Acer Therapeutics Inc made up ﹤0.01% of Knight Capital Group's portfolio in Q2 2013, its #3054 holding.
  • 12 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.